{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpce.simplecast.com%2Fepisodes%2Feuas-whats-available-inpatient-part-1-ch9oFDEJ","width":444,"version":"1.0","type":"rich","title":"EUAs: What’s Available Inpatient? Part 1","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/947d3b7f-3890-4e80-8529-6486b02916d4/50c13836-459a-4ef5-9882-9e0a953f467d/covid-podcast-euas-whats-available-inpatient-part-1-episode2.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/ef7fed81-7604-4d3b-8811-45b9380a2e42\" height=\"200\" width=\"100%\" title=\"EUAs: What’s Available Inpatient? Part 1\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"This episode is the first half of an expert discussion on treatments for COVID-19 in the hospital setting. The episode covers the latest information on the use of convalescent plasma and remdesivir, including the available efficacy data, when to administer treatment, and potential toxicities to expect. Claim your credit at pce.is/COV19."}